@WHO: @DrTedros @G20 "Yesterday, we recommended the use of IL-6 receptor blockers, a type of monoclonal antibody, in patients with severe or critical #COVID19. This treatment, along with corticosteroids, is recommended for patients with severe or critical disease"-@DrTedros https://t.co/32Wum8HJYX

@WHO: @DrTedros @G20 "Yesterday, we recommended the use of IL-6 receptor blockers, a type of monoclonal antibody, in patients with severe or critical #COVID19. This treatment, along with corticosteroids, is recommended for patients with severe or critical disease"-@DrTedros https://t.co/32Wum8HJYX

http://twitter.com/WHO
via IFTTT

Comments